Device
sonolysis
sonolysis is a medical device with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
50%(2 trials)
Phase Distribution
Ph not_applicable
3
60%
Ph phase_3
2
40%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 3Large-scale testing
2(40.0%)
N/ANon-phased studies
3(60.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(4)
Other(1)
Detailed Status
Completed4
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 32 (40.0%)
N/A3 (60.0%)
Trials by Status
unknown120%
completed480%
Recent Activity
0 active trials
Showing 5 of 5
unknownnot_applicable
TransCranial Doppler for REDUCtion of Silent strokE During MitraClip Implantation
NCT04384198
completednot_applicable
SONOlysis in Prevention of Brain InfaRctions During Internal Carotid Endarterectomy
NCT02398734
completedphase_3
SONOlysis in Risk REduction of Symptomatic and Silent Brain infarCtions dUring Cardiac surgEry
NCT01591018
completednot_applicable
Sonolysis in Risk Reduction of Symptomatic and Silent Brain Infarctions During Coronary Stenting
NCT02351050
completedphase_3
SONOlysis in Prevention of Brain Infarctions dUring Carotid Stenting and caroTid EndaRterectomy
NCT01591005
Clinical Trials (5)
Showing 5 of 5 trials
NCT04384198Not Applicable
TransCranial Doppler for REDUCtion of Silent strokE During MitraClip Implantation
NCT02398734Not Applicable
SONOlysis in Prevention of Brain InfaRctions During Internal Carotid Endarterectomy
NCT01591018Phase 3
SONOlysis in Risk REduction of Symptomatic and Silent Brain infarCtions dUring Cardiac surgEry
NCT02351050Not Applicable
Sonolysis in Risk Reduction of Symptomatic and Silent Brain Infarctions During Coronary Stenting
NCT01591005Phase 3
SONOlysis in Prevention of Brain Infarctions dUring Carotid Stenting and caroTid EndaRterectomy
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5